deltatrials
Terminated PHASE2 NCT00878215

Clinical Application of Image-Guided Liver Surgery

Sponsor: Washington University School of Medicine

Conditions Hepatocellular Cancer
Interventions Explorer Liver Image Guided System Explorer Liver Passive Tracking Liver abalation Liver surgery
Updated 8 times since 2017 Last updated: Jan 16, 2018 Started: Oct 24, 2002 Primary completion: May 25, 2011 Completion: May 25, 2011

A PHASE2 clinical study on Hepatocellular Cancer, this trial is terminated or withdrawn. The trial is conducted by Washington University School of Medicine and has accumulated 8 data snapshots since 2002. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  5. Feb 2020 — Jan 2021 [monthly]

    Terminated PHASE2

▶ Show 3 earlier versions

  1. Jun 2018 — Feb 2020 [monthly]

    Terminated PHASE2

  2. Mar 2018 — Jun 2018 [monthly]

    Terminated PHASE2

    Status: Unknown Status → Terminated · Phase: NA → PHASE2

  3. Jan 2017 — Mar 2018 [monthly]

    Unknown Status NA

    First recorded

Oct 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Washington University School of Medicine
Data source: Washington University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • St Louis, United States